Javascript must be enabled to continue!
Truncated Trk Action
View through CrossRef
Neurotrophins promote neuron survival and maturation and support the development and function of neural tissue and organs. They bind to and activate receptor tyrosine kinases of the Trk family. However, truncated forms of TrkB and TrkC that lack the intracellular kinase domain are expressed primarily in glial cells, and their function has not been so clear. They have been presumed to play a passive role, sequestering neurotrophins or inhibiting full-length receptors through dimerization. Rose
et al.
combined calcium imaging and electrophysiology to observe a direct role of a truncated form TrkB (TrkB-T1) in mediating the effects of brain-derived neurotrophic factor (BDNF) in cultured astrocytes and glia. BDNF evoked a transient increase in intracellular calcium that required the activation of phospholipase C (PLC), which generates inositol trisphosphate (IP
3
), and a heterotrimeric GTP-binding protein (G protein) that is insensitive to pertussis toxin. The calcium wave was blocked by an inhibitor of the IP
3
receptor that controls calcium release from intracellular compartments. The expression of TrkB-T1 was more than 100 times that of full-length TrkB in glia, and BDNF-induced currents were the same in glia derived from either wild-type mice or mice lacking full-length TrkB. Reduction of TrkB1-T1 expression by an antisense approach reduced the amplitude of BDNF-evoked calcium transients by 45%. The authors propose that TrkB1-T1 stimulates the release of calcium from intracellular stores through a G protein-PLC-IP
3
receptor pathway in astroctyes and glia. This may control the release of neurotransmitters and other molecules that affect neuron function.
C. R. Rose, R. Blum, B. Pichler, A. Lepier, K. W. Kafits, A. Konnerth, Truncated TrkB1-T1 mediates neurotrophin-evoked calcium signalling in glia cells.
Nature
426
, 74-78 (2003).
[Online Journal]
Title: Truncated Trk Action
Description:
Neurotrophins promote neuron survival and maturation and support the development and function of neural tissue and organs.
They bind to and activate receptor tyrosine kinases of the Trk family.
However, truncated forms of TrkB and TrkC that lack the intracellular kinase domain are expressed primarily in glial cells, and their function has not been so clear.
They have been presumed to play a passive role, sequestering neurotrophins or inhibiting full-length receptors through dimerization.
Rose
et al.
combined calcium imaging and electrophysiology to observe a direct role of a truncated form TrkB (TrkB-T1) in mediating the effects of brain-derived neurotrophic factor (BDNF) in cultured astrocytes and glia.
BDNF evoked a transient increase in intracellular calcium that required the activation of phospholipase C (PLC), which generates inositol trisphosphate (IP
3
), and a heterotrimeric GTP-binding protein (G protein) that is insensitive to pertussis toxin.
The calcium wave was blocked by an inhibitor of the IP
3
receptor that controls calcium release from intracellular compartments.
The expression of TrkB-T1 was more than 100 times that of full-length TrkB in glia, and BDNF-induced currents were the same in glia derived from either wild-type mice or mice lacking full-length TrkB.
Reduction of TrkB1-T1 expression by an antisense approach reduced the amplitude of BDNF-evoked calcium transients by 45%.
The authors propose that TrkB1-T1 stimulates the release of calcium from intracellular stores through a G protein-PLC-IP
3
receptor pathway in astroctyes and glia.
This may control the release of neurotransmitters and other molecules that affect neuron function.
C.
R.
Rose, R.
Blum, B.
Pichler, A.
Lepier, K.
W.
Kafits, A.
Konnerth, Truncated TrkB1-T1 mediates neurotrophin-evoked calcium signalling in glia cells.
Nature
426
, 74-78 (2003).
[Online Journal].
Related Results
Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease
Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease
The neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 bind to the tyrosine kinase (trk) receptors trk A, trk B and trk C, respectively, with h...
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract
Background: Gene fusions involving members of the NTRK family have been identified in several types of cancer. The use of TRK inhibitors in vitro and in viv...
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Little is known about the signal transduction pathways of TRK family receptors in neuroblastoma (NB) cells. In this study, an NB cell line, designated MP‐N‐TS, was established from...
An Ancestral Trk Receptor
An Ancestral Trk Receptor
No true invertebrate homologs of the vertebrate neurotrophin Trk receptors have been identified in the genomes of the model organisms
Drosophila melanogaster
...
Normal ve Keratokonuslu Gözlerde TRK-2P Cihazının Güvenilirliğinin Değerlendirilmesi: Bir Ön Gözlem
Normal ve Keratokonuslu Gözlerde TRK-2P Cihazının Güvenilirliğinin Değerlendirilmesi: Bir Ön Gözlem
Bu çalışmanın amacı TRK-2P cihazı (Topcon Medical Systems Inc., Oakland NJ) ile elde edilen keratometri ve kornea kalınlık değerlerini, Pentacam-HR cihazı (Oculus; Optikgeräte GmbH...
Trk Uses ARMS to Sustain Signals
Trk Uses ARMS to Sustain Signals
Similar signaling pathways are used in particular contexts to control a wide range of distinct biological processes. However, the molecular mechanisms by which specificity is attai...
Role of Neurotrophin-Trk Interactions in Oncology: The Anti-tumor Efficacy of Potent and Selective Trk Tyrosine Kinase Inhibitors in Pre-Clinical Tumor Models
Role of Neurotrophin-Trk Interactions in Oncology: The Anti-tumor Efficacy of Potent and Selective Trk Tyrosine Kinase Inhibitors in Pre-Clinical Tumor Models
The increasing knowledge of the pathogenic mechanisms involved in cancer cell growth has enabled the implementation of mechanism based drug design approaches rather than...
Bayesian Models for Zero Truncated Count Data
Bayesian Models for Zero Truncated Count Data
It is important to fit count data with suitable model(s), models such as Poisson Regression, Quassi Poisson, Negative Binomial, to mention but a few have been adopted by researcher...

